AU476000B2 - 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts - Google Patents

2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts

Info

Publication number
AU476000B2
AU476000B2 AU44886/72A AU4488672A AU476000B2 AU 476000 B2 AU476000 B2 AU 476000B2 AU 44886/72 A AU44886/72 A AU 44886/72A AU 4488672 A AU4488672 A AU 4488672A AU 476000 B2 AU476000 B2 AU 476000B2
Authority
AU
Australia
Prior art keywords
propionoxylidide
amino
acceptable salts
therapeutically acceptable
therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU44886/72A
Other versions
AU4488672A (en
Inventor
NICHOL BOYES BENJAMIN RANDALL DUCE EMIL RICHARD SMITH; and EUGENE WILLIAM BYRNES ROBERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of AU4488672A publication Critical patent/AU4488672A/en
Application granted granted Critical
Publication of AU476000B2 publication Critical patent/AU476000B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU44886/72A 1971-07-28 1972-07-24 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts Expired AU476000B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16703171A 1971-07-28 1971-07-28
USUS167,031 1971-07-28

Publications (2)

Publication Number Publication Date
AU4488672A AU4488672A (en) 1974-01-31
AU476000B2 true AU476000B2 (en) 1976-09-09

Family

ID=22605664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44886/72A Expired AU476000B2 (en) 1971-07-28 1972-07-24 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts

Country Status (23)

Country Link
JP (1) JPS565220B1 (en)
AR (1) AR193748A1 (en)
AT (1) AT317185B (en)
AU (1) AU476000B2 (en)
BE (1) BE786875A (en)
BR (1) BR7205069D0 (en)
CA (1) CA982148A (en)
CH (1) CH574397A5 (en)
CS (1) CS171171B2 (en)
DD (1) DD101389A5 (en)
DK (1) DK142843B (en)
ES (1) ES404739A1 (en)
FI (1) FI55492C (en)
FR (1) FR2147277B1 (en)
GB (1) GB1374367A (en)
HU (1) HU163818B (en)
IE (1) IE36607B1 (en)
NL (1) NL176254C (en)
NO (1) NO137500C (en)
PL (1) PL84891B1 (en)
SE (1) SE399702B (en)
SU (1) SU441704A3 (en)
ZA (1) ZA724512B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57182525U (en) * 1981-05-15 1982-11-19
JPH01128053U (en) * 1988-02-24 1989-08-31
JP2514855B2 (en) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 Acid addition salts of optically active alanine anilide derivatives
GB2267709A (en) * 1992-06-11 1993-12-15 Merck & Co Inc Novel process for the preparation of alpha-aminoacylanilides
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
DE102012210082A1 (en) * 2012-06-15 2013-12-19 Hilti Aktiengesellschaft Machine tool and control method
MX2018001447A (en) 2015-08-03 2019-02-21 Harvard College Charged ion channel blockers and methods for use.
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
JP2022527438A (en) 2019-03-11 2022-06-02 ノシオン セラピューティクス，インコーポレイテッド Charged ion channel blockers and usage
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023500891A (en) 2019-11-06 2023-01-11 ノシオン セラピューティクス，インコーポレイテッド Charged ion channel blockers and methods of use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Also Published As

Publication number Publication date
NO137500B (en) 1977-11-28
NL7210418A (en) 1973-01-30
DD101389A5 (en) 1973-11-05
CA982148A (en) 1976-01-20
HU163818B (en) 1973-11-28
FR2147277B1 (en) 1976-04-16
AT317185B (en) 1974-08-12
PL84891B1 (en) 1976-04-30
AR193748A1 (en) 1973-05-22
CH574397A5 (en) 1976-04-15
NO137500C (en) 1978-03-08
DE2235745A1 (en) 1973-02-22
SE399702B (en) 1978-02-27
NL176254C (en) 1985-03-18
IE36607L (en) 1973-01-28
BE786875A (en) 1973-01-29
BR7205069D0 (en) 1973-07-17
DK142843C (en) 1981-08-31
FR2147277A1 (en) 1973-03-09
ZA724512B (en) 1973-08-29
IE36607B1 (en) 1976-12-08
SU441704A3 (en) 1974-08-30
JPS565220B1 (en) 1981-02-04
ES404739A1 (en) 1975-07-16
GB1374367A (en) 1974-11-20
AU4488672A (en) 1974-01-31
DK142843B (en) 1981-02-09
FI55492B (en) 1979-04-30
CS171171B2 (en) 1976-10-29
NL176254B (en) 1984-10-16
FI55492C (en) 1979-08-10
DE2235745B2 (en) 1976-08-19

Similar Documents

Publication Publication Date Title
AU476000B2 (en) 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts
AU465934B2 (en) Preparation of d,d'-2,2'-(ethylenedimino) -di-1-butanol hydrochloride
CA963468A (en) Derives de l'isoquinoleine
CA953107A (en) Panneau d'affichage
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
CA992079A (en) Optically active 1,4-benzodiazepines and process for the preparation thereof
CA989842A (en) 2-mercapto-pyrido(1,2-6)1,2,4-thiodiazolium salts and derivatives thereof
CA882705A (en) 5,8-dihydronaphthyloxy-amino-propanols and related compounds
CA984386A (en) 2-halo-2',3',5'-tri-0-acylinosines and the production thereof
AU467915B2 (en) 2, 5-substituted thiasiazoles and their preparation
CA885976A (en) N-(d-6-methyl-8-isoergolenyl)-n',n'-diethylcarbamide and physiologically acceptable salts thereof
CA924733A (en) Pseudothioureas and their salts
AU473794B2 (en) 2',3',5'-tri-o-nicotinoyl-4-thiouridine
CA874984A (en) Levo-1-n-butyl-2',6'-pipecoloxylidide
CA863355A (en) 1-n-methyl-(4'-butoxy-2',6'-dimethylbenzoylamino)-methyl-pyridines and pyrrolidines
CA875569A (en) 3,3'-bis-2-pyrazolines
CA874440A (en) 6,1'-spirocyclopropylprogesterones
CA860343A (en) 2-(n'-(o-alkoxyphenyl) piperazinomethyl)-3-quinuclidinone
CA889345A (en) 4'-phenoxyalkanesulfonanilides
CA885439A (en) 3-ethylenedioxy gona-4,9,11-trienes
CA863959A (en) N,n'-alkylene-bis-dibenzobicyclo-octanopyrrolidine compounds and production thereof
CA873352A (en) 1,2,3,4-tetrahydro-isoquinolines and their preparation
CA870627A (en) 1,3,4-thiazolidine-2-thiones and their preparation
AU462250B2 (en) Pharmaceutically active triazenomidazoles
AU455249B2 (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds